
Since the introduction of zzso chemotherapy for advanced solid tumors in the 1990s, the median overall survival of patients with zzso breast cancer increased from 2 years to almost 5 zzso Similarly, the zzso overall survival for zzso cancer has increased from zzso to more than zzso 

zzso is a novel zzso compound, with similar zzso and zzso properties of zzso and is active in zzso cell zzso Over 1200 patients have been treated with zzso in Phase I - III clinical trials and a wealth of knowledge has accumulated about this zzso This review discusses current pharmacology and data from clinical trials with zzso from the last seven zzso 

We present a comprehensive summary of data from Phase II and III trials, as well as an overview of currently zzso zzso 

Although zzso has not demonstrated superiority over zzso zzso zzso in a large Phase III trial in relapsed or zzso zzso cancer, its evaluation is continuing in a range of other zzso especially in primary or secondary tumors of the zzso 

